We are live on
!
Find out more
Bio-Rad Laboratories Class A
BIO
BIO
469 hedge funds and large institutions have $8.68B invested in Bio-Rad Laboratories Class A in 2020 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 161 increasing their positions, 154 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
171% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 38
33% more capital invested
Capital invested by funds: $6.54B → $8.68B (+$2.14B)
16% more funds holding
Funds holding: 406 → 469 (+63)
2.47% more ownership
Funds ownership: 76.12% → 78.59% (+2.5%)
9% more call options, than puts
Call options by funds: $11.6M | Put options by funds: $10.6M
5% more repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 154
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Holders
469
Holders Change
+63
Holders Change %
+15.52%
% of All Funds
9.62%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.14%
New
103
Increased
161
Reduced
154
Closed
38
Calls
$11.6M
Puts
$10.6M
Net Calls
+$963K
Net Calls Change
+$7.17M
Top Buyers
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$130M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$129M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$117M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$114M |
| 5 |
State Street
Boston,
Massachusetts
|
+$106M |
